diagnosis of coexisting moderate-to-severe carotid artery stenosis, as determined using computed tomography ... All participants underwent a visual acuity examination using a Snellen chart. Each ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

European research led by University College London (UCL), together with Amsterdam UMC and the University of Basel, shows that a significant proportion of patients who suffer a stroke due to carotid ...

Terumo Neuro's Carotid Stent System is indicated for the treatment of carotid artery stenosis in patients at increased risk for adverse events following carotid endarterectomy. The device is ...

First Dual-Layer Micromesh Carotid Stent Approved for Use in the U.S. ALISO VIEJO, Calif., April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular ...

A new study published in Nature Cardiovascular Research found that while carotid artery narrowing can lead to stroke in both ...

The investigators randomized 1,004 patients (mean age 68 years; 31% women) with symptomatic or asymptomatic internal carotid artery stenosis ≥ 70% to either sonolysis or a sham intervention during ...

Although my bias as a CAS enthusiast makes me believe that CAS will ultimately have a major role in the treatment of patients with carotid stenosis, and although results of CAS will ultimately ...

The most effective treatment for carotid artery stenosis is carotid endarterectomy (CEA). To date, randomized trials of this procedure versus best medical care have excluded patients aged 80 years ...

MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke ...